Bank Hapoalim BM’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bank Hapoalim BM’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,353	Closed	-$223K	–	173
2019 Q1	$223K	Sell	4,353 -516	-11%	-$25.7K	0.05%	151
2018 Q4	$228K	Hold	4,869	–	–	0.07%	140
2018 Q3	$272K	Sell	4,869 -405	-8%	-$22.1K	0.07%	163
2018 Q2	$266K	Sell	5,274 -1,440	-21%	-$71.4K	0.07%	162
2018 Q1	$330K	Sell	6,714 -294	-4%	-$15.1K	0.09%	149
2017 Q4	$361K	Sell	7,008 -1,785	-20%	-$91.7K	0.08%	147
2017 Q3	$458K	Sell	8,793 -2,100	-19%	-$108K	0.1%	145
2017 Q2	$563K	Sell	10,893 -5,580	-34%	-$282K	0.13%	111
2017 Q1	$829K	Buy	16,473 +6,702	+69%	+$332K	0.19%	98
2016 Q4	$460K	Buy	9,771 +5,121	+110%	+$243K	0.12%	121
2016 Q3	$232K	Hold	4,650	–	–	0.05%	174
2016 Q2	$224K	Buy	+4,650	New	+$221K	0.05%	160
2015 Q3	–	Sell	-4,650	Closed	-$271K	–	170
2015 Q2	$271K	Sell	4,650 -164,160	-97%	-$9.59M	0.05%	158
2015 Q1	$1.61M	Buy	168,810 +164,160	+3,530%	+$8.98M	0.29%	61
2014 Q4	$234K	Hold	4,650	–	–	0.05%	144
2014 Q3	$218K	Hold	4,650	–	–	0.05%	146
2014 Q2	$209K	Hold	4,650	–	–	0.05%	145
2014 Q1	$200K	Buy	+4,650	New	+$195K	0.05%	138

Other funds holding IHE

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank Hapoalim BM's IHE Position: Q2 2019 in Review

Bank Hapoalim BM sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2019, closing a stake of 4,353 shares — an estimated $223K sold.

Bank Hapoalim BM first reported a position in IHE in Q1 2014 and held it in 18 quarters. The position peaked at $1.61M in Q1 2015. 87 funds tracked by Wall St. Rank hold IHE as of Q2 2019.

Bank Hapoalim BM reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2019 after selling out during the quarter.
Bank Hapoalim BM sold 4,353 iShares US Pharmaceuticals ETF shares in Q2 2019, an estimated $223K.
Bank Hapoalim BM first reported a position in iShares US Pharmaceuticals ETF in Q1 2014 and held it in 18 quarters.
Bank Hapoalim BM's iShares US Pharmaceuticals ETF position peaked at $1.61M in Q1 2015.
87 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2019.

Based on Bank Hapoalim BM's 13F filing for Q2 2019, filed 6 Aug 2019.